NCT07922018 AI-assisted Home-based Intervention for ADHD Children
| NCT ID | NCT07922018 |
| Status | Recruiting |
| Phase | — |
| Sponsor | National Taiwan University Hospital |
| Condition | ADHD - Attention Deficit Disorder With Hyperactivity |
| Study Type | INTERVENTIONAL |
| Enrollment | 120 participants |
| Start Date | 2026-08-01 |
| Primary Completion | 2027-07-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 120 participants in total. It began in 2026-08-01 with a primary completion date of 2027-07-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this clinical trial is to evaluate the effectiveness of online diary platforms for socio-emotional learning training in children with attention deficit hyperactivity disorder (ADHD). The main questions it aims to answer are: Does the online diary platform training enhance children's emotion regulation and its connection to positive thinking? Does the online diary platform training provide an immediate, interactive, and effective emotion training tool during the wait for follow-up visits and treatment? Researchers will compare online diary platforms training to counselling to see if online diary platforms training enhance children's emotion regulation. Participants will use the MangaChat diary platform to log their daily moods and events, which the platform transforms into comic strips to offer an engaging visual story of their emotional experiences. Participants are requested to use the platform daily (or at least 3 times per week) for approximately 10 to 15 minutes per session over a 12-week period.
Eligibility Criteria
Inclusion Criteria: * Children aged 8-12 years with a professional diagnosis of Attention-Deficit/Hyperactivity Disorder (ADHD), who are enrolled in the study only after obtaining informed consent from their parents or legal guardians, as well as the assent of the children themselves. Exclusion Criteria: * Intellectual disability, defined as a Full Scale Intelligence Quotient (FSIQ) score of less than 70. * Severe language or communication impairments. * Lack of access to internet-connected devices. * Inability to effectively use the platform for mood logging and self-reflection.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07922018 clinical trial?
This trial is open to participants of all sexes, aged 8 Years or older, up to 12 Years, studying ADHD - Attention Deficit Disorder With Hyperactivity. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07922018 currently recruiting?
Yes, NCT07922018 is actively recruiting participants. Contact the research team at cheong.pouleng@gmail.com for enrollment information.
Where is the NCT07922018 trial being conducted?
This trial is being conducted at Hsinchu, Taiwan.
Who is sponsoring the NCT07922018 clinical trial?
NCT07922018 is sponsored by National Taiwan University Hospital. The trial plans to enroll 120 participants.